Rockwell Medical, Inc. operates as an integrated biopharmaceutical company targeting end-stage renal and chronic kidney diseases in the United States and internationally. The company's lead drug includes Triferic, an iron maintenance therapy that replaces the iron lost by patients during hemodialysis treatment. It also provides Calcitriol, a generic active vitamin D injection, which is indicated for the treatment of secondary hyperparathyroidism in dialysis patients. In addition, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, Renalpure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate; and ancillary products, including blood tubings, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Its concentrated dialysate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. Rockwell Medical, Inc. sells its products directly, as well as through independent sales agents and distributors. The company's target customers include senior and operating management of dialysis companies, dialysis service providers, nephrologists, clinic administrators, nurses, medical directors, and technical and purchasing personnel. Rockwell Medical, Inc. was founded in 1995 and is based in Wixom, Michigan.
Industry, Sector and Symbol
Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Phone248-960-9009
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$57.30 million
Profitability
Miscellaneous
Employees300
OptionableOptionable
Rockwell Medical (NASDAQ:RMTI) Frequently Asked Questions
What is Rockwell Medical's stock symbol?
Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI."
How were Rockwell Medical's earnings last quarter?
Rockwell Medical Inc (NASDAQ:RMTI) announced its quarterly earnings data on Tuesday, August, 14th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.13) by $0.09. The firm had revenue of $14.91 million for the quarter, compared to the consensus estimate of $14.90 million. Rockwell Medical had a negative net margin of 53.40% and a negative return on equity of 117.31%. View Rockwell Medical's Earnings History.
When is Rockwell Medical's next earnings date?
What price target have analysts set for RMTI?
1 brokers have issued 12 month price targets for Rockwell Medical's stock. Their predictions range from $11.00 to $11.00. On average, they expect Rockwell Medical's share price to reach $11.00 in the next year. This suggests a possible upside of 139.7% from the stock's current price. View Analyst Price Targets for Rockwell Medical.
What is the consensus analysts' recommendation for Rockwell Medical?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rockwell Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Rockwell Medical.
Has Rockwell Medical been receiving favorable news coverage?
News articles about RMTI stock have trended somewhat positive on Thursday, according to InfoTrie. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Rockwell Medical earned a daily sentiment score of 1.7 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an impact on the company's share price in the immediate future.
Who are some of Rockwell Medical's key competitors?
Some companies that are related to Rockwell Medical include Natus Medical (BABY), Viewray (VRAY), AxoGen (AXGN), BioLife Solutions (BLFS), Semler Scientific (SMLR), Cutera (CUTR), Electrocore (ECOR), Helius Medical Technologies (HSDT), Zynex (ZYXI), Fonar (FONR), Stereotaxis (STXS), BioSig Technologies (BSGM), Edap Tms (EDAP), IRIDEX (IRIX) and Second Sight Medical Products (EYES).
Who are Rockwell Medical's key executives?
Rockwell Medical's management team includes the folowing people:
- Dr. Ajay Gupta, Chief Scientific Officer & Member of Scientific Advisory Board (Age 61)
- Dr. Raymond Dennis Pratt, Chief Medical Officer (Age 68)
- Mr. Stuart Paul, Pres, CEO & Director
- Mr. Angus W. Smith, Chief Financial Officer (Age 36)
- Mr. Michael DeYoung, VP of Operations
Who are Rockwell Medical's major shareholders?
Rockwell Medical's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (5.67%), Northern Trust Corp (1.08%), Geode Capital Management LLC (0.95%), Bank of New York Mellon Corp (0.43%), BKS Advisors LLC (0.38%) and Perritt Capital Management Inc. (0.29%). Company insiders that own Rockwell Medical stock include David S Richmond and Kenneth L Holt. View Institutional Ownership Trends for Rockwell Medical.
Which institutional investors are selling Rockwell Medical stock?
RMTI stock was sold by a variety of institutional investors in the last quarter, including Raymond James & Associates, BKS Advisors LLC, Perritt Capital Management Inc., Northern Trust Corp, Stifel Financial Corp and Oppenheimer & Co. Inc.. View Insider Buying and Selling for Rockwell Medical.
Which institutional investors are buying Rockwell Medical stock?
RMTI stock was purchased by a variety of institutional investors in the last quarter, including D. E. Shaw & Co. Inc., Geode Capital Management LLC, SG Americas Securities LLC, AdvisorNet Financial Inc, Rhumbline Advisers, Starfire Investment Advisers Inc., Provident Investment Management Inc. and Rehmann Capital Advisory Group. View Insider Buying and Selling for Rockwell Medical.
How do I buy shares of Rockwell Medical?
Shares of RMTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Rockwell Medical's stock price today?
One share of RMTI stock can currently be purchased for approximately $4.59.
How big of a company is Rockwell Medical?
Rockwell Medical has a market capitalization of $261.53 million and generates $57.30 million in revenue each year. The company earns $-25,920,000.00 in net income (profit) each year or ($0.51) on an earnings per share basis. Rockwell Medical employs 300 workers across the globe.
What is Rockwell Medical's official website?
How can I contact Rockwell Medical?
Rockwell Medical's mailing address is 30142 S WIXOM RD, WIXOM MI, 48393. The company can be reached via phone at 248-960-9009 or via email at [email protected]
MarketBeat Community Rating for Rockwell Medical (NASDAQ RMTI)
MarketBeat's community ratings are surveys of what our community members think about Rockwell Medical and other stocks. Vote "Outperform" if you believe RMTI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RMTI will underperform the S&P 500 over the long term. You may vote once every thirty days.
